Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
07/2003
07/24/2003US20030139583 Process for preparation of anhydrous azithromycin
07/24/2003US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
07/24/2003US20030139388 Antiinflammatory agents; osteoporosis
07/24/2003US20030138510 Stabilizing proanthocyanidin with an amino acid having a hydroxyl group or its dipeptide
07/24/2003CA2471311A1 Aromatic thioether liver x-receptor modulators
07/23/2003CN1432019A Hygromycin derivatives for treatment of bacterial and protozoal infections
07/23/2003CN1115149C Aqueous process for mfg. paroxetine solid dispersions
07/22/2003US6596759 Medicament for treatment of irritable bowel syndrome
07/22/2003US6596737 C10 carbamoyloxy substituted taxanes
07/22/2003US6596722 Serotonin reuptake inhibitors/HT3 receptor antagonists useful for treatment of depression, psychosis, anxiety disorders, panic disorder, obsessive compulsive disorder, and eating disorders
07/17/2003US20030134801 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
07/17/2003US20030134274 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
07/17/2003US20030134148 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
07/16/2003EP1326860A1 Quinazoline derivatives
07/16/2003EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them
07/16/2003EP0830137B1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
07/16/2003CN1114602C Ketone derivatives and medicinal use thereof
07/15/2003US6593480 Obesity, hyperglycemia
07/10/2003WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
07/10/2003WO2001098248A3 Hiv integrase inhibitors
07/10/2003US20030130173 Bactericides for drug resistant bacteria
07/09/2003CN1429225A C10 carbonate substituted taxanes as antitumor agents
07/09/2003CN1428340A 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method
07/09/2003CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/08/2003US6589984 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as
07/03/2003WO2003053948A1 Isochroman compounds for treatment of cns disorders
07/03/2003WO2003053437A1 Triazoles as oxytocin antagonists
07/03/2003WO2002016340A8 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
07/03/2003US20030125572 Useful as a cosmetic constituent, antioxidant, radical scavenger or anti-inflammatory agent
07/03/2003US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
07/03/2003US20030125339 Substituted alkylamine derivatives and methods of use
07/03/2003CA2469278A1 Isochroman compounds for treatment of cns disorders
07/03/2003CA2469042A1 Triazoles as oxytocin antagonists
07/02/2003EP1323716A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
07/02/2003EP1322644A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
07/02/2003EP1322599A2 Hiv integrase inhibitors
07/02/2003EP0970067B1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors
07/02/2003EP0841916B1 Endothelin receptor antagonists
07/01/2003US6586441 Adenosine receptor ligands and their use in the treatment of disease
06/2003
06/26/2003US20030120096 Reacting racemic beta-lactam with lithium- 7-protected baccatin III- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents
06/26/2003US20030120094 For improved binding of CB1/CB2 receptors; side effects reduction
06/26/2003US20030119914 Bis(thio-hydrazide amide) compounds; anticancer agents
06/26/2003US20030119816 Cycline-dependent kinase protein inhibitors; antiproliferative agents
06/25/2003CN1426410A Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof
06/25/2003CN1425664A Di-pentaheterocycle substituted fulgide photochromic compounds and its synthetic method and use
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2002060434A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
06/19/2003US20030114493 Antitumor agents
06/19/2003US20030114419 Taxane derivatives having a tricyclic or tetracyclic core; remarkable properties in vitro; valuable antileukemia, antitumor and anticarcinogenic agents; human cancer cell line comparable to that of taxol and taxotere
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1319666A1 Novel antibacterial compounds
06/18/2003EP1319406A1 Novel antibacterial compounds
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003CN1425004A N-substituted metal proteinase inhibitor with heterocyclic side chain
06/12/2003WO2003047565A1 Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives
06/12/2003US20030109578 Treating acute and chronical inflammatory processes in a patent in need thereof which comprises administering to such patent an amount effective therefor of a compound or salt thereof according to claim 1.
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/10/2003US6576771 Pesticides, herbicides and fungicides
06/10/2003US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/05/2003US20030105343 Benzofuran compounds
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/04/2003EP1315719A1 Multivalent neuraminidase inhibitor conjugates
06/04/2003EP1315710A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315709A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0934296B1 Chroman derivatives
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/03/2003CA2273446C Piperidones
05/2003
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/29/2003US20030100772 Oxygen-containing heterocyclic compounds
05/29/2003US20030100083 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture
05/29/2003US20030099756 Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
05/28/2003EP1313749A2 Process for preparation of anhydrous azithromycin
05/28/2003EP1206462B1 Heterocyclic compounds inhibiting angiogenesis
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1109029C oxygenic heterocyclic compounds
05/21/2003CN1109026C Sidechain-beering taxanes like compounds
05/20/2003US6566373 For therapy of osteoporosis, periodontitis, and arthritis
05/15/2003WO2003040136A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040134A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003US20030092852 Epoxy resin composition, cured article thereof, novel epoxy resin, novel phenol compound, and process for preparing the same
05/15/2003US20030092755 Novel prodrugs for antimicrobial amidines
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP0667772B1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 120